Epidemiologic data on the incidence of different types of pyelonephritis are limited. It is known that the incidence of acute pyelonephritis is highest in otherwise healthy women between 15 and 29 years of age, followed by infants and older persons.
DiastatÂ® comes in easy-to-use, prepackaged, pre -measured doses. It requires no refrigeration or special handling and has a 4-year shelf life. DiastatÂ® comes in 10 mg or 20 mg syringes for use in adults with a range of dosing from 5 mg to 20 mg. The pharmacist will dial in the correct dose on the pre-filled syringe and lock it into place. A green âREADYâ band should be visible when the unit is locked. Side effects There may be side effects to the use of DiastatÂ® which include:
In the management of ACS, initiate BRILINTA treatment with a 180 mg loading dose. Administer 90 mg twice daily during the first year after an ACS event. After one year administer 60 mg twice daily. Do not administer BRILINTA with another oral P2Y12 platelet inhibitor. Use BRILINTA with a daily maintenance dose of aspirin of 75-100 mg [see Warnings and Precautions (5.2) and Clinical Studies (14.1)]. A patient who misses a dose of BRILINTA should take one tablet (their next dose) at its scheduled time.